Literature DB >> 16202386

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight.

Antje Körner1, Martin Wabitsch, Bertolt Seidel, Pamela Fischer-Posovszky, Antje Berthold, Michael Stumvoll, Matthias Blüher, Jürgen Kratzsch, Wieland Kiess.   

Abstract

Adiponectin is an adipocytokine with profound anti-diabetic and anti-atherogenic effects. Even though adiponectin expression is restricted to adipocytes, serum levels are paradoxically decreased in obesity. We characterized how adiponectin expression and regulation relates to adipocyte differentiation in a human adipocyte cell culture model. Adiponectin was not expressed by human preadipocytes. Differentiation into adipocytes was necessary to induce an increasing expression of adiponectin (359 +/- 64-fold, P < 0.001) in parallel to an increasing expression of adipocyte differentiation markers. Adiponectin protein synthesis and secretion occurred specifically in mature adipocytes and may thus serve as a distinctive marker of adipocyte differentiation. Addition of serum during the course of differentiation as well as acutely to mature adipocytes significantly and concentration-dependently suppressed adiponectin to almost non-detectable levels (to 9.8 +/- 0.03%, P = 0.0043), suggesting a strong humoral serum component of adiponectin down-regulation. This serum component is present in both obese and lean individuals with a tendency to a stronger effect in obese men and women. Separation by molecular size suggests that higher molecular weight (>30 kDa) fractions exert inhibition of adiponectin. Withdrawal of adipogenic ingredients from the culture medium also resulted in a decrease of adiponectin expression and secretion to 62.01 +/- 0.09% and 70.86 +/- 0.05%, respectively. We identified insulin as a critical component to maintain adiponectin expression with a down-regulation to 61.6 +/- 0.1% (P = 0.0011) in the absence of insulin. These dynamic changes of adiponectin expression and regulation with adipocyte differentiation are of physiological interest in the light of the paradoxical decrease of adiponectin levels and the continuous recruitment of preadipocytes for differentiation in obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202386     DOI: 10.1016/j.bbrc.2005.09.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  METRNL decreases during adipogenesis and inhibits adipocyte differentiation leading to adipocyte hypertrophy in humans.

Authors:  D Löffler; K Landgraf; D Rockstroh; J T Schwartze; H Dunzendorfer; W Kiess; A Körner
Journal:  Int J Obes (Lond)       Date:  2016-10-17       Impact factor: 5.095

2.  Higher adiponectin levels predict greater weight gain in healthy women in the Nurses' Health Study.

Authors:  Marie-France Hivert; Qi Sun; Peter Shrader; Christol S Mantzoros; James B Meigs; Frank B Hu
Journal:  Obesity (Silver Spring)       Date:  2010-09-02       Impact factor: 5.002

3.  A protocol for the isolation and cultivation of brown bear (Ursus arctos) adipocytes.

Authors:  J L Gehring; K S Rigano; B D Evans Hutzenbiler; O L Nelson; C T Robbins; H T Jansen
Journal:  Cytotechnology       Date:  2016-02-08       Impact factor: 2.058

4.  Functional relevance of genes implicated by obesity genome-wide association study signals for human adipocyte biology.

Authors:  F Bernhard; K Landgraf; N Klöting; A Berthold; P Büttner; D Friebe; W Kiess; P Kovacs; M Blüher; A Körner
Journal:  Diabetologia       Date:  2012-11-16       Impact factor: 10.122

5.  Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women.

Authors:  Jyh Kae Nien; Shali Mazaki-Tovi; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Francesca Gotsch; Beth L Pineles; Ricardo Gomez; Samuel Edwin; Moshe Mazor; Jimmy Espinoza; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2007       Impact factor: 1.901

6.  A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2.

Authors:  Ying Wu; He Gao; Huaixing Li; Yasuharu Tabara; Masahiro Nakatochi; Yen-Feng Chiu; Eun Jung Park; Wanqing Wen; Linda S Adair; Judith B Borja; Qiuyin Cai; Yi-Cheng Chang; Peng Chen; Damien C Croteau-Chonka; Marie P Fogarty; Wei Gan; Chih-Tsueng He; Chao A Hsiung; Chii-Min Hwu; Sahoko Ichihara; Michiya Igase; Jaeseong Jo; Norihiro Kato; Ryuichi Kawamoto; Christophor W Kuzawa; Jeannette J M Lee; Jianjun Liu; Ling Lu; Thomas W McDade; Haruhiko Osawa; Wayne H-H Sheu; Yvonne Teo; Swarooparani Vadlamudi; Rob M Van Dam; Yiqin Wang; Yong-Bing Xiang; Ken Yamamoto; Xingwang Ye; Terri L Young; Wei Zheng; Jingwen Zhu; Xiao-Ou Shu; Chol Shin; Sun Ha Jee; Lee-Ming Chuang; Tetsuro Miki; Mitsuhiro Yokota; Xu Lin; Karen L Mohlke; E Shyong Tai
Journal:  Hum Mol Genet       Date:  2013-10-08       Impact factor: 6.150

7.  Adipogenic signaling in rat white adipose tissue: modulation by aging and calorie restriction.

Authors:  Min Zhu; Garrick D Lee; Liusong Ding; Jingping Hu; Guang Qiu; Rafa de Cabo; Michel Bernier; Donald K Ingram; Sige Zou
Journal:  Exp Gerontol       Date:  2007-06-06       Impact factor: 4.032

8.  Impact of metabolic regulators on the expression of the obesity associated genes FTO and NAMPT in human preadipocytes and adipocytes.

Authors:  Daniela Friebe; Dennis Löffler; Maria Schönberg; Falk Bernhard; Petra Büttner; Kathrin Landgraf; Wieland Kiess; Antje Körner
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

9.  Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes.

Authors:  Ivan Nagaev; Maria Bokarewa; Andrej Tarkowski; Ulf Smith
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Phasing of muscle gene expression with fasting-induced recovery growth in Atlantic salmon.

Authors:  Neil I Bower; Richard G Taylor; Ian A Johnston
Journal:  Front Zool       Date:  2009-08-24       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.